The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection

BACKGROUND: Stage I non-small cell lung cancer (NSCLC) is potentially curable, and surgery is considered to be the standard of care for patients with good performance status and minimal co-morbidity. However, a significant proportion of patients with stage I NSCLC have a poorer performance status an...

Descripción completa

Detalles Bibliográficos
Autores principales: Snee, M. P., McParland, L., Collinson, F., Lowe, C. M., Striha, A., Baldwin, D. R., Naidu, B., Sebag-Montefiore, D., Gregory, W. M., Bestall, J., Hewison, J., Hinsley, S., Franks, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153694/
https://www.ncbi.nlm.nih.gov/pubmed/27965826
http://dx.doi.org/10.1186/s40814-016-0046-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5153694/
https://www.ncbi.nlm.nih.gov/pubmed/27965826
http://dx.doi.org/10.1186/s40814-016-0046-2

Ejemplares similares